The Hindu Business Line : US co to market JB Chemicals' Ciprofloxacin

JB Chemicals and Pharmaceuticals Ltd on Monday announced the supply, marketing and distribution of its Ciprofloxacin will be exclusively managed by Lannett Company Inc, USA, through an agreement with its joint venture partner Spectrum Pharmaceuticals, USA.

"The US FDA has already accepted the company's ANDA Filing for Ciprofloxacin and approval is expected by this year-end. The company expects to generate revenues from the US sales of Ciprofloxacin in 2004," a release said.

Article E-Mail :: Comment :: Syndication

Stories in this Section
US co to market JB Chemicals' Ciprofloxacin

Correction

Herbertsons: Mallya may make counter offer

SC clears decks for Parke-Davis, Pfizer merger

IFC sells part stake in Rain Calcining

Move to change name of ICWAI gains momentum

Bajaj Auto signs new wage pact

Eminent Luggages, Ricossa Marketing form joint venture

P&G Hygiene announces 1:2 bonus shares

Toyota-Kirloskar to reduce production cost by 50 pc

Volvo India targets 15% turnover growth — Focus on being 'logistics enabler'

Goodlass Nerolac bets on auto, housing sectors

Taj group pins hopes on organic growth — To foray into Spa services

Tata Tea to expand in US with Tetley — To rationalise green leaf operations

South strong in R&D sector — North-based cos pay little heed to marketing: Study